PL409015A1 - N-sulfonic derivative of polyallylamine, application of N-sulfonic derivative of polyallylamine as a medicine, preferably for the prevention and treatment of infection of respiratory tract induced by the human metapneumovirus (hMPV) and the pharmaceutical composition containing the N-sulfonic derivate of polyallylamine - Google Patents

N-sulfonic derivative of polyallylamine, application of N-sulfonic derivative of polyallylamine as a medicine, preferably for the prevention and treatment of infection of respiratory tract induced by the human metapneumovirus (hMPV) and the pharmaceutical composition containing the N-sulfonic derivate of polyallylamine

Info

Publication number
PL409015A1
PL409015A1 PL409015A PL40901514A PL409015A1 PL 409015 A1 PL409015 A1 PL 409015A1 PL 409015 A PL409015 A PL 409015A PL 40901514 A PL40901514 A PL 40901514A PL 409015 A1 PL409015 A1 PL 409015A1
Authority
PL
Poland
Prior art keywords
polyallylamine
sulfonic
derivative
hmpv
pharmaceutical composition
Prior art date
Application number
PL409015A
Other languages
Polish (pl)
Other versions
PL228171B1 (en
Inventor
Maria Nowakowska
Krzysztof Szczubiałka
Krzysztof Pyrć
Justyna Ciejka
Aleksandra Milewska
Original Assignee
Uniwersytet Jagielloński
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Jagielloński filed Critical Uniwersytet Jagielloński
Priority to PL409015A priority Critical patent/PL228171B1/en
Priority to EP15763979.0A priority patent/EP3174908B1/en
Priority to PCT/IB2015/055727 priority patent/WO2016016820A2/en
Priority to CA2955406A priority patent/CA2955406A1/en
Priority to US15/329,324 priority patent/US20170216347A1/en
Publication of PL409015A1 publication Critical patent/PL409015A1/en
Priority to US15/792,962 priority patent/US9925215B1/en
Publication of PL228171B1 publication Critical patent/PL228171B1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Przedmiotem wynalazku jest N-sulfonowa pochodna polialliloaminy (NSPAH) o wzorze 1, w którym R oznacza -SO3 albo -H, a n oznacza liczbę całkowitą od 150 do 15000, zastosowanie N-sulfonowej pochodnej polialliloaminy jako leku, zwłaszcza do profilaktyki i leczenia infekcji dróg oddechowych, wywołanych ludzkim metapneumowirusem (hMPV) oraz kompozycja farmaceutyczna zawierająca N-sulfonową pochodną polialliloaminy i jej zastosowanie.The subject of the invention is a N-sulfone polyallylamine derivative (NSPAH) of the formula 1, wherein R is -SO3 or -H and n is an integer from 150 to 15000, the use of the N-sulfone polyallylamine derivative as a medicament, especially for the prophylaxis and treatment of respiratory infections respiratory diseases caused by human metapneumovirus (hMPV) and a pharmaceutical composition comprising an N-sulfone polyallylamine derivative and its use.

PL409015A 2014-07-29 2014-07-29 N-sulfonic derivative of polyallylamine, application of N-sulfonic derivative of polyallylamine as a medicine, preferably for the prevention and treatment of infection of respiratory tract induced by the human metapneumovirus (hMPV) and the pharmaceutical composition containing the N-sulfonic derivate of polyallylamine PL228171B1 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
PL409015A PL228171B1 (en) 2014-07-29 2014-07-29 N-sulfonic derivative of polyallylamine, application of N-sulfonic derivative of polyallylamine as a medicine, preferably for the prevention and treatment of infection of respiratory tract induced by the human metapneumovirus (hMPV) and the pharmaceutical composition containing the N-sulfonic derivate of polyallylamine
EP15763979.0A EP3174908B1 (en) 2014-07-29 2015-07-29 Anionically modified n-sulfonic polyallylamine derivative, pharmaceutical composition comprising the n-sulfonic polyallylamine derivative as the active substance and use of the n-sulfonic polyallylamine derivative for the production of a medicine
PCT/IB2015/055727 WO2016016820A2 (en) 2014-07-29 2015-07-29 Anionically modified polyallylamine derivative, use of anionically modified polyallylamine derivative as medicine, particularly for propylaxis and treatment of infections of respiratory tract caused by human metapneumovirus (hmpv), human rhinoviruses (hrv), and infection by influenza virus type a (iav) and pharmaceutical composition comprising the anionically modified polyallylamine derivative
CA2955406A CA2955406A1 (en) 2014-07-29 2015-07-29 Anionically modified polyallylamine derivative, use of anionically modified polyallylamine derivative as medicine, particularly for propylaxis and treatment of infections of respiratory tract caused by human metapneumovirus (hmpv), human rhinoviruses (hrv), and infection by influenza virus type a (iav) and pharmaceutical composition comprising the...
US15/329,324 US20170216347A1 (en) 2014-07-29 2015-07-29 Anionically modified polyallylamine derivative, use of anionically modified polyallylamine derivative as medicine, particularly for propylaxis and treatment of infections of respiratory tract caused by human metapneumovirus (hmpv), human rhinoviruses (hrv), and infection by influenza virus type a (iav) and pharmaceutical composition comprising the anionically modified polyallylamine derivative
US15/792,962 US9925215B1 (en) 2014-07-29 2017-10-25 Anionically modified polyallylamine derivative, use of anionically modified polyallylamine derivative as medicine, particularly for propylaxis and treatment of infections of respiratory tract caused by human metapneumovirus (hMPV), human rhinoviruses (HRV), and infection by influenza virus type A (IAV) and pharmaceutical composition comprising the anionically modified polyallylamine derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL409015A PL228171B1 (en) 2014-07-29 2014-07-29 N-sulfonic derivative of polyallylamine, application of N-sulfonic derivative of polyallylamine as a medicine, preferably for the prevention and treatment of infection of respiratory tract induced by the human metapneumovirus (hMPV) and the pharmaceutical composition containing the N-sulfonic derivate of polyallylamine

Publications (2)

Publication Number Publication Date
PL409015A1 true PL409015A1 (en) 2016-02-01
PL228171B1 PL228171B1 (en) 2018-02-28

Family

ID=55178445

Family Applications (1)

Application Number Title Priority Date Filing Date
PL409015A PL228171B1 (en) 2014-07-29 2014-07-29 N-sulfonic derivative of polyallylamine, application of N-sulfonic derivative of polyallylamine as a medicine, preferably for the prevention and treatment of infection of respiratory tract induced by the human metapneumovirus (hMPV) and the pharmaceutical composition containing the N-sulfonic derivate of polyallylamine

Country Status (1)

Country Link
PL (1) PL228171B1 (en)

Also Published As

Publication number Publication date
PL228171B1 (en) 2018-02-28

Similar Documents

Publication Publication Date Title
PH12019550050A1 (en) Isoxazole analogs as fxr agonists and methods of use thereof
MX2022010520A (en) Peptide macrocycles against acinetobacter baumannii.
GEP20217248B (en) 2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of dhodh
MX2016013529A (en) Amide derivatives and pharmaceutically acceptable salts thereof, preparation method therefor and medicinal application thereof.
NZ733174A (en) Quinazoline derivatives used to treat hiv
EA202090486A3 (en) COMPOUNDS FOR THE TREATMENT OF SPINAL MUSCLE ATROPHY
NZ751197A (en) Compounds and methods of treating infections
EA201891063A1 (en) DERIVATIVES OF DIHYDROIMIDAZOPIRAZINONE APPLICABLE IN THE TREATMENT OF CANCER
BR112015003188A2 (en) COMPOUND, PHARMACEUTICAL COMPOSITION, COMPOUND USE, AND METHOD FOR TREATMENT OF A RORGAMMAT-MEDIATED DISEASE OR CONDITION IN A PATIENT
CR20180253A (en) THERAPEUTIC COMPOSITIONS FOR THE TREATMENT OF HUMAN UNMUNODEFICIENCY VIRUS
PH12016502353A1 (en) Pharmaceutical composition
PH12016502352A1 (en) Pharmaceutical composition
NZ607580A (en) N-heteroaryl compounds
EA201590364A1 (en) APPLICATION OF AIRWAY PERSON, HIS SALTS AND CRYSTALLINE FORMS AND COMPOSITIONS, ITS CONTAINING, FOR THE TREATMENT OF ZUD
PH12016502039A1 (en) Potent and selective inhibitors of hepatitis c virus
EA201692111A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING DANIRYXIN FOR TREATING INFECTIOUS DISEASES
EA201792264A1 (en) METHODS OF TREATING INFLAMMATORY DISEASES
MX2019007213A (en) Condensed ring group azacyclobutyl triazole derivative, preparation method therefor and use thereof in medicine.
MX2018002177A (en) Novel catechol derivative and pharmaceutical composition comprising same.
BR112016029619A8 (en) FLUOROQUINOLONE CLASS COMPOUNDS, PHARMACEUTICAL COMPOSITION AND DRUG COMPRISING SUCH COMPOUNDS AND USES OF SUCH COMPOUNDS
PH12016502480A1 (en) Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases
PL409015A1 (en) N-sulfonic derivative of polyallylamine, application of N-sulfonic derivative of polyallylamine as a medicine, preferably for the prevention and treatment of infection of respiratory tract induced by the human metapneumovirus (hMPV) and the pharmaceutical composition containing the N-sulfonic derivate of polyallylamine
EA201792265A1 (en) METHODS OF TREATING CARDIOVASCULAR DISEASES
WO2016016820A3 (en) Anionically modified n-sulfonic polyallylamine derivative, pharmaceutical composition comprising the n-sulfonic polyallylamine derivative as the active substance and use of said derivate for the production of a medicine
EA201692532A1 (en) ANTIMICROBIAL COMPOSITIONS WITH PIPE SUBSTANCES